Syntegra Private Wealth Group LLC Buys 173 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Syntegra Private Wealth Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% in the fourth quarter, Holdings Channel reports. The fund owned 2,689 shares of the healthcare conglomerate’s stock after acquiring an additional 173 shares during the period. Syntegra Private Wealth Group LLC’s holdings in UnitedHealth Group were worth $1,416,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Richelieu Gestion SA bought a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. Robbins Farley bought a new stake in UnitedHealth Group during the 3rd quarter worth about $25,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC grew its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $35,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH traded up $1.60 during trading hours on Thursday, hitting $494.70. 3,805,551 shares of the company were exchanged, compared to its average volume of 4,097,774. The company has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a P/E/G ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm’s fifty day moving average is $503.10 and its 200 day moving average is $518.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue was up 14.1% compared to the same quarter last year. During the same period last year, the firm posted $5.34 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens reiterated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Finally, Piper Sandler cut their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.